Compare Mutual Funds

Pros
5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

Lower expense ratio.

Lower expense ratio.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
4/8
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

7 Years 9 Months

13 Years 3 Months

Fund AUM

₹2640 Cr

₹7875 Cr

Min Investment
  1. SIP ₹99
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.48%

0.92%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

35

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(12.11%)
  2. Divi's Laboratories Ltd(8.52%)
  3. Glenmark Pharmaceuticals Ltd(7%)
  4. Apollo Hospitals Enterprise Ltd(6.21%)
  5. Lupin Ltd(5.54%)
  1. Sun Pharmaceuticals Industries Ltd(12.67%)
  2. Lupin Ltd(7.88%)
  3. Divi's Laboratories Ltd(6.54%)
  4. Dr Reddy's Laboratories Ltd(6.06%)
  5. Cipla Ltd(5.88%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(98.95%)
  2. Basic Materials(1.05%)

Health

(100%)

Equity %

99.75%

98.97%

Debt %

-

-

P/E

38.73

34.75

P/B

5.16

5.37

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

0.83%

1.18%

3-Month Return

-1.78%

-2.27%

6-Month Return

-1.6%

-2.12%

1-Year Return

10.08%

9.95%

3-Year Return

24.03%

23.59%

5-Year Return

16.41%

15.65%

Sharpe

0.92

0.97

Alpha

-0.59

0.33

Beta

0.98

0.9

Standard Deviation

16.5

15.32

Information Ratio

-0.34

-0.32

Description

Mirae Asset Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Vrijesh Kasera, Tanmay Mehta

Sailesh Raj Bhan, Divya Sharma, Lokesh Maru, Kinjal Desai

Most Popular Comparisons